Citation Impact
Citing Papers
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Cardiovascular risk factors in long‐term followup after orthotopic liver transplantation
1997
Calcineurin Inhibitors FK506 and SDZ ASM 981 Alleviate the Outcome of Focal Cerebral Ischemic/Reperfusion Injury
1999
Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles
1999
Chronic Allograft Rejection
1993
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
Pharmacokinetics of recombinant human interleukin‐2 in advanced renal cell carcinoma patients following subcutaneous application
1998
Chipping into the human genome: novel insights for transplantation
2006
Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR)
2000
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
1999
Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures
1993
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Effective oral administration of tacrolimus in renal transplant recipients
2001
Inhibition of intestinal ischemia/repurfusion induced apoptosis and necrosis via down-regulation of the NF-kB, c-Jun and caspace-3 expression by epigallocatechin-3-gallate administration
2008
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002
Post-Transplant Diabetes Mellitus The Role of Immunosuppression
1997
GB virus type C interactions with HIV: the role of envelope glycoproteins
2009
Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis
2020 StandoutNobel
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae
2010
New Immunosuppressive Agents for Maintenance Therapy in Organ Transplantation
1997
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Mycophenolate Mofetil Can Prevent the Development of Diabetes in BB Ratsa
1993
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Management of chronic viral hepatitis before and after renal transplantation
2002
Delivery technologies for cancer immunotherapy
2019 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
2000
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
REVIEW: Ischemia—Reperfusion Injury of the Intestine and Protective Strategies Against Injury
2004
SEQUENTIAL CYTOKINE EXPRESSION IN RENAL ALLOGRAFTS IN RATS IMMUNOSUPPRESSED WITH MAINTENANCE CYCLOSPORINE OR MYCOPHENOLATE MOFETIL1
1996
Combination Effect of Mycophenolate Mofetil with Mizoribine on Cell Proliferation Assays and in a Mouse Heart Transplantation Model
2006
Treating hepatitis C
2005 StandoutNobel
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
1999 Standout
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Treatment with Vitamin D and Calcium Reduces Bone Loss after Renal Transplantation
2002
Hepatitis C Viral Infection in Liver Transplantation
1996
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate Mofetil
1993
The design and development of an immunosuppressive drug, mycophenolate mofetil
1993
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Tacrolimus
1997
Mycophenolate mofetil and its mechanisms of action
2000 Standout
The Use of Tacrolimus in Pediatric Liver Transplantation
1998
Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism
1995
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up
2004
Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
1997
Osteoporosis after solid organ and bone marrow transplantation
2003
miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence
2017 StandoutNobel
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts
1995
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Neurological complications after orthotopic liver transplantation
2007
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
ROLE OF TACROLIMUS IN THE EVOLUTION OF LIVER TRANSPLANTATION
2004
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
The role of immunosuppression in recurrence of hepatitis C
2003
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
2001 Standout
Effect of mycophenolate mofetil (RS-61443) on cytokine production: inhibition of superantigen-induced cytokines
1993
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Effects of Immunosuppressants on Induction of Regulatory Cells After Intratracheal Delivery of Alloantigen
2005
A selective role of calcineurin Aα in synaptic depotentiation in hippocampus
1999 StandoutNobel
Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus
2015
Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes
1994
Evidence for Circulating Bone Marrow-Derived Endothelial Cells
1998 Standout
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Tacrolimus
2000
Characterization of human type I and type II IMP dehydrogenases.
1993
Copper and Iron Disorders of the Brain
2007
A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
1996 Standout
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product
2018 StandoutNobel
Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro
2014
Viraemic frequencies and seroprevalence of non-primate hepacivirus and equine pegiviruses in horses and other mammalian species
2014
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
Quantitation of Viral Load Using Real-Time Amplification Techniques
2001
Synergism Between Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease Among Lethally Irradiated Dogs Given DLA-Nonidentical Unrelated Marrow Grafts
1998
Therapeutic Monitoring of Tacrolimus
1998
Identification of a Pegivirus (GB Virus-Like Virus) That Infects Horses
2013 StandoutNobel
Ischemic Cell Death in Brain Neurons
1999 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury
2010 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation
2005 StandoutNobel
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Works of K.-P. Platz being referenced
Cytokine pattern in patients with infections after liver transplantation
1996
The combined treatment with L-arginine and methylprednisolone improves graft morphology and mucosal barrier function
2002
Influence of Immunosuppression on Patient Outcome After Liver Transplantation
1998
Dynamics of Gb Virus C Viremia Early After Orthotopic Liver Transplantation Indicates Extrahepatic Tissues As the Predominant Site of Gb Virus C Replication
1999
RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENT
1991
IL-10 Increases Tissue Injury After Selective Intestinal Ischemia/Reperfusion
2003
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation
2001
Mycophenolate mofetil in combination with tacrolimus versus neoral after liver transplantation
1999
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation
1998
Indications for Mycophenolate Mofetil Therapy in Hepatitis C-Patients Undergoing Liver Transplantation
1998
Liver transplantation in neurologic Wilson’s disease
2001
Is the use of marginal liver grafts justified?
1999
Changes at the extracellular matrix during acute and chronic rejection in human liver transplantation
1998
Indication for mycophenolate mofetil therapy in hepatitis c patients undergoing liver transplantation
1998
RS-61443 studies: review and proposal.
1991
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.
1994
Treatment of osteoporosis after liver transplantation.
1995
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
1996
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
1995
PREDNISOLONE WITHDRAWAL AFTER PANCREAS-KIDNEY TRANSPLANTATION IN PATIENTS TREATED WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL
1999
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients.
1994
Long-term follow-up in hepatitis C patients with respect to immunosuppression.
1996
Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
1994
Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
1996
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease.
1994
Changes at the extracellular matrix during acute and chronic rejection in human liver transplantation
1998